Burney Co. Invests $1.84 Million in Addus HomeCare Corporation $ADUS

Key Points

• Burney Co. bought a new stake of 17,142 shares in Addus HomeCare valued at approximately $1.84 million, representing about 0.09% ownership.
• Insiders sold 16,610 shares in the last quarter (about $1.77 million), reducing insider ownership to 4.50% after EVP sales by David Tucker and Brian Poff.
• Analysts' consensus rates Addus as a "Moderate Buy" with a consensus price target of $133.22, while the stock trades near $95 and the company has a market cap of about $1.77 billion.

Burney Co. bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 17,142 shares of the company's stock, valued at approximately $1,841,000. Burney Co. owned 0.09% of Addus HomeCare as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Azzad Asset Management Inc. ADV lifted its stake in Addus HomeCare by 3.0% during the fourth quarter. Azzad Asset Management Inc. ADV now owns 11,088 shares of the company's stock worth $1,191,000 after purchasing an additional 321 shares during the period. Harbor Capital Advisors Inc. grew its stake in shares of Addus HomeCare by 16.9% in the 4th quarter. Harbor Capital Advisors Inc. now owns 29,295 shares of the company's stock valued at $3,146,000 after purchasing an additional 4,239 shares during the period. Chatham Capital Group Inc. grew its stake in shares of Addus HomeCare by 0.9% in the 4th quarter. Chatham Capital Group Inc. now owns 20,603 shares of the company's stock valued at $2,213,000 after purchasing an additional 190 shares during the period. Exchange Traded Concepts LLC raised its holdings in shares of Addus HomeCare by 1.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 18,198 shares of the company's stock worth $1,954,000 after buying an additional 296 shares in the last quarter. Finally, Net Worth Advisory Group raised its holdings in shares of Addus HomeCare by 18.6% in the 4th quarter. Net Worth Advisory Group now owns 3,210 shares of the company's stock worth $345,000 after buying an additional 503 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Insider Buying and Selling

In other news, EVP David W. Tucker sold 704 shares of the firm's stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total value of $75,574.40. Following the completion of the sale, the executive vice president directly owned 10,802 shares in the company, valued at approximately $1,159,594.70. This trade represents a 6.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Brian Poff sold 2,041 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $218,346.18. Following the completion of the transaction, the executive vice president directly owned 64,512 shares of the company's stock, valued at $6,901,493.76. This represents a 3.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 16,610 shares of company stock valued at $1,768,970. Insiders own 4.50% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on ADUS. KeyCorp reaffirmed an "overweight" rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Truist Financial set a $135.00 price objective on Addus HomeCare and gave the company a "buy" rating in a report on Wednesday, January 7th. Wall Street Zen downgraded shares of Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, March 21st. Finally, Barclays lowered their target price on shares of Addus HomeCare from $112.00 to $102.00 and set an "underweight" rating on the stock in a report on Wednesday, March 25th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of "Moderate Buy" and a consensus price target of $133.22.

Addus HomeCare Stock Up 3.1%

Shares of ADUS opened at $95.09 on Tuesday. The company has a market capitalization of $1.77 billion, a P/E ratio of 18.25, a PEG ratio of 1.27 and a beta of 0.96. Addus HomeCare Corporation has a one year low of $90.89 and a one year high of $124.43. The business's 50 day simple moving average is $102.69 and its 200-day simple moving average is $109.61. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.80.

About Addus HomeCare

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.